» Articles » PMID: 12351949

HLA Typing in a Kenyan Cohort Identifies Novel Class I Alleles That Restrict Cytotoxic T-cell Responses to Local HIV-1 Clades

Overview
Journal AIDS
Date 2002 Sep 28
PMID 12351949
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate HLA class I allele frequencies in a Kenyan commercial sex worker (CSW) cohort, and to examine HIV-1 specific cytotoxic T lymphocyte (CTL) responses directed against epitopes derived from locally prevalent clade A virus.

Methods: PCR-single strand polymorphism HLA class I typing. Sequencing of novel alleles and examination of their distribution in the CSW cohort, and a low risk HIV uninfected cohort. The peptide-binding motif of a novel class I allele was predicted, and a panel of candidate CTL epitopes was synthesized whose functional significance was examined using ELISpot and Cr release assays.

Results: Class I HLA-A and B frequencies within the cohort are presented. Two novel class I alleles were found, HLA-B*4415 and HLA-Cw*0407. These two class I alleles were relatively common, both in the CSW cohort (2.1% and 3.3% respectively) and in a cohort of lower risk women (1.9% and 3.8% respectively). Allele HLA-B*4415 restricted CTL responses against a novel epitope (EEKAFSPEV) derived from p24 of clade A HIV-1, and HLA-Cw0407 restricted CTL against a predefined HLA-Cw*0401 gp120 epitope.

Conclusions: Multi-epitope vaccine design requires knowledge of HLA class I distribution and HIV CTL epitope characterization in potential target populations. The description of two novel HLA class I alleles at high frequency in this high risk Kenyan CSW cohort suggests that HLA mapping of vaccine cohorts and subsequent characterization of local CTL epitopes will be warranted prior to vaccine trials.

Citing Articles

Specificity of CD8 T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya.

Mohamed Y, Borthwick N, Moyo N, Murakoshi H, Akahoshi T, Siliquini F Vaccines (Basel). 2020; 8(2).

PMID: 32485938 PMC: 7349992. DOI: 10.3390/vaccines8020260.


HIV-1 progression links with viral genetic variability and subtype, and patient's HLA type: analysis of a Nairobi-Kenyan cohort.

Abidi S, Shahid A, Lakhani L, Shah R, Okinda N, Ojwang P Med Microbiol Immunol. 2013; 203(1):57-63.

PMID: 24142198 DOI: 10.1007/s00430-013-0314-1.


High resolution human leukocyte antigen class I allele frequencies and HIV-1 infection associations in Chinese Han and Uyghur cohorts.

Liu Y, Zhao Z, Li T, Liao Q, Kushner N, Touzjian N PLoS One. 2012; 7(12):e50656.

PMID: 23251376 PMC: 3520934. DOI: 10.1371/journal.pone.0050656.


HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response.

Piantadosi A, Chohan B, Panteleeff D, Baeten J, Mandaliya K, Ndinya-Achola J AIDS. 2009; 23(5):579-87.

PMID: 19516110 PMC: 2727980. DOI: 10.1097/QAD.0b013e328328f76e.


Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1.

Mackelprang R, John-Stewart G, Carrington M, Richardson B, Rowland-Jones S, Gao X J Infect Dis. 2008; 197(8):1156-61.

PMID: 18462163 PMC: 2689391. DOI: 10.1086/529528.